Immuno-oncology of differentiated thyroid cancer
نویسندگان
چکیده
منابع مشابه
Thyroid hormone replacement one day before 131I therapy in patients with well-differentiated thyroid cancer
Objective: The current study aimed to determine the efficacy of radioiodine-131 (131I) ablation therapy with thyroid hormone replacement one day before 131I administration in patients with well-differentiated thyroid cancer (DTC). Methods: This retrospective study included 29 patients who underwent 131I therapies twice for DTC during 6-12 months. Since all the patients obviously had residual l...
متن کاملDifferentiated Thyroid Cancer in Asians
In the past two decades, thyroid cancer has rapidly increased around the world, including in Korea [1]. Although the exact cause of this increase is still under debate, cancer screening with high-resolution ultrasound (US) might have led to earlier diagnosis of smaller thyroid cancers [2-4]. However, the increased incidence across all tumor sizes suggests that a higher rate of detection of smal...
متن کاملThe immuno-oncology framework
Developers of cancer immunotherapy have struggled for decades to achieve clinical success in using the patient's immune system to treat cancer. In the absence of a defined development paradigm for immunotherapies, conventional criteria established for chemotherapy were applied to these agents. This article summarizes the recent lessons for development of agents in the immunotherapy space, descr...
متن کاملPrecision Immuno-Oncology: Prospects of Individualized Immunotherapy for Pancreatic Cancer
Pancreatic cancer, most commonly referring to pancreatic ductal adenocarcinoma (PDAC), remains one of the most deadly diseases, with very few effective therapies available. Emerging as a new modality of modern cancer treatments, immunotherapy has shown promises for various cancer types. Over the past decades, the potential of immunotherapy in eliciting clinical benefits in pancreatic cancer hav...
متن کاملEvaluation of the Differentiated Thyroid Cancer and the Results of the 131 Administration
Differentiated thyroid cancers (follicular and papillary) are in the group of the cancers with relatively good prognosis and most of them have tendency to absorb the Iodine, so the 131 is used for tlie ablation of the thyroid tissue, rest of the tumor and metastases. This study revealed that for this purpose most of the Iranian's patients (more than 70%)have been hospitalized more than once and...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International Journal of Molecular & Immuno Oncology
سال: 2021
ISSN: 2456-3994
DOI: 10.25259/ijmio_36_2020